
How We Review Lab Software
At BestLabTech, we review lab software the way we wish someone had reviewed it for us: independently, carefully, and with the working scientist or lab manager in mind.
This page explains how we research the platforms we cover (LIMS, ELNs, lab automation, inventory and scheduling tools, billing and RCM systems, and the integration layers that tie them together) and how we decide what to recommend.
Who’s behind the reviews
BestLabTech is written by Dr. Colm O’Regan, who spent years at the bench before moving into science communication. That background, a PhD in materials science, published research, and hands-on lab experience, is the reason I can read a vendor’s spec sheet and tell the difference between a real capability and a marketing claim.
Our review process
Every review follows the same five steps.
1. Map the use case before the product. Lab software is one of the most context-dependent categories in B2B. A LIMS that’s perfect for a high-throughput environmental testing lab can be the wrong tool for a discovery-stage biotech, and an ELN built for chemistry teams can be a poor fit for clinical diagnostics. So before we look at any vendor, we define the buyer we’re writing for: lab type, sample volume, regulatory environment (CLIA, CAP, GLP, GMP, ISO 17025, 21 CFR Part 11), team size, and the specific problem the software is meant to solve.
2. Vendor research. We pull together everything publicly available on each platform: documentation, technical specs, pricing pages where they exist, demo videos, webinars, conference talks, security and compliance pages, integration directories, API docs, release notes, and recent product announcements. We also read the company signals, funding, hiring, leadership stability, customer logos, because a great product from a vendor that’s about to fold is still a bad bet.
3. Independent user feedback. We read long, specific reviews across G2, Capterra, TrustRadius, and Software Advice, and we follow discussions on Reddit and in LinkedIn lab-manager and informatics communities. We weight detailed reviews far more heavily than star ratings, and we pay particular attention to recurring complaints. Those are the problems that surface six months after the contract is signed, not on the demo call.
4. Peer and expert input. Where we can, we talk to lab managers, directors, QA leads, and informatics specialists who have actually deployed the platform, and we factor in the perspective of analysts and consultants who know the space.
5. Hands-on evaluation where feasible. When a vendor offers a trial, sandbox, or guided demo, we use it. We try to run a representative workflow (an actual sample submission, an experiment template, a stock check, a billing run) to see how the system feels in practice rather than how it looks in a marketing video. Hands-on access isn’t always possible, and when it isn’t, we say so in the review.
How we score
Lab software is ultimately judged on one thing: does it help a lab work faster, stay compliant, and scale without breaking? We assess seven criteria against that standard.
Core functionality. Does the platform actually do the job it’s sold to do? For a LIMS: sample tracking, accessioning, chain of custody, results reporting, instrument integration. For an ELN: experiment capture, templating, search, versioning, structured data entry. For inventory tools: real-time stock visibility, reagent tracking, expiry alerts, reorder workflows.
Ease of use and adoption. A rollout fails when scientists won’t use the thing. We look at the interface, the learning curve, daily workflow friction, and the quality of training and onboarding, plus how well the system serves the different roles in a lab, from bench scientist to QA reviewer to IT admin.
Integrations and interoperability. Modern labs run on dozens of instruments and adjacent systems. A platform that can’t talk to your analyzers, ERP, EHR, accounting system, or data lake creates more silos than it removes. We assess integration breadth (what’s supported out of the box), depth (real bidirectional data flow, not just file imports), and API quality (REST, webhooks, documentation, rate limits, SDK availability).
Compliance, security, and data integrity. Non-negotiable for any regulated lab. We evaluate support for 21 CFR Part 11, HIPAA, GDPR, ISO 17025, GxP, and CLIA/CAP as relevant to the platform’s market: audit trails, electronic signatures, access controls, role-based permissions, encryption at rest and in transit, validation documentation, SOC 2 status, and the vendor’s track record on security incidents.
Scalability and configurability. Labs evolve: workflows change, volumes grow, new assays come online, regulations shift. We distinguish configurability (what a lab admin can change in the UI without code) from customization (changes that need developer time and professional-services fees). Platforms that lock most of their flexibility behind paid customization score lower, because that flexibility is rarely as flexible as the sales deck implies.
Vendor support, viability, and implementation. You’re not just buying a product. You’re buying a multi-year partnership. We look at implementation methodology, how realistic the stated timelines are, support-tier depth, response-time SLAs, and the availability of professional services for migration and validation.
Total cost of ownership. The license sticker price is rarely what a lab actually pays. We look at the full picture: per-user vs per-instance pricing, implementation fees, validation costs, custom integration work, training, ongoing support tiers, and how predictable renewal pricing is.
A note on independence and bias
BestLabTech is an independent advisor. We don’t accept payment in exchange for higher rankings or favorable mentions, and our editorial recommendations aren’t influenced by any commercial relationship we may have with a company we cover.
When a commercial relationship does exist, whether a vendor advertises elsewhere on the site or one of us has done paid work for them in the past, we disclose it directly in the review, in the byline or methodology section, not buried in a footer. We’d rather tell you about a conflict and let you weigh it than pretend we operate in a vacuum.
Why you can trust our reviews
Most lab software content falls into two buckets: vendor blogs that quietly rank their own product first, and directory listings that rank whoever pays the most. Neither helps a real buyer.
We try to do something different. We name trade-offs. We recommend against a product when the fit is wrong. We point you to alternatives when our top pick isn’t right for your situation. And we update reviews as products change and as we learn more from readers and from the field.
If something in a review doesn’t match your experience with a platform, or there’s a tool you’d like us to cover, we want to hear it. Reach us through the contact form; we read every message.
The goal is simple: be the most trustworthy independent voice in lab software.
A note on buyer responsibility
Our reviews are a strong starting point, not a substitute for your own due diligence. We research thoroughly, score fairly, and surface the trade-offs that matter, but every lab is different, and the final purchasing decision is, and should be, yours.
Before you sign with any vendor, we strongly recommend you:
- Book a live demo and walk through your actual workflows, not the vendor’s standard demo script.
- Take the free trial where one exists, and put the people who’ll use the system day-to-day in front of it.
- Talk to current customers at your scale and in your industry, ideally ones the vendor hasn’t hand-picked. Reddit threads are good for finding them.
- Get pricing, implementation, validation, and support costs in writing, renewal terms included.
- Bring in IT, security, QA, and compliance early, not after the contract is signed.
BestLabTech is not a party to any agreement between you and a software vendor, and we’re not responsible for the outcome of any purchase, implementation, or contractual relationship that follows from reading our content. Use our reviews as one input among several, and trust your own evaluation above all.
